Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,833 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Downregulation of Fas ligand by shedding.
Tanaka M, Itai T, Adachi M, Nagata S. Tanaka M, et al. Among authors: nagata s. Nat Med. 1998 Jan;4(1):31-6. doi: 10.1038/nm0198-031. Nat Med. 1998. PMID: 9427603
Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure.
Ryo K, Kamogawa Y, Ikeda I, Yamauchi K, Yonehara S, Nagata S, Hayashi N. Ryo K, et al. Among authors: nagata s. Am J Gastroenterol. 2000 Aug;95(8):2047-55. doi: 10.1111/j.1572-0241.2000.02268.x. Am J Gastroenterol. 2000. PMID: 10950056
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.
Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N. Kuwano K, et al. Among authors: nagata s. J Clin Invest. 1999 Jul;104(1):13-9. doi: 10.1172/JCI5628. J Clin Invest. 1999. PMID: 10393694 Free PMC article.
Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
Kaser A, Nagata S, Tilg H. Kaser A, et al. Among authors: nagata s. Cytokine. 1999 Oct;11(10):736-43. doi: 10.1006/cyto.1998.0484. Cytokine. 1999. PMID: 10525311
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H. Hashimoto W, et al. Among authors: nagata s. J Immunol. 1999 Jul 15;163(2):583-9. J Immunol. 1999. PMID: 10395644
Levels of soluble Fas ligand in myocarditis.
Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Toyozaki T, et al. Among authors: nagata s. Am J Cardiol. 1998 Jul 15;82(2):246-8. doi: 10.1016/s0002-9149(98)00300-2. Am J Cardiol. 1998. PMID: 9678301
Fas-induced apoptosis.
Nagata S. Nagata S. Intern Med. 1998 Feb;37(2):179-81. doi: 10.2169/internalmedicine.37.179. Intern Med. 1998. PMID: 9550601 Review. No abstract available.
Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
Hashimoto H, Tanaka M, Suda T, Tomita T, Hayashida K, Takeuchi E, Kaneko M, Takano H, Nagata S, Ochi T. Hashimoto H, et al. Among authors: nagata s. Arthritis Rheum. 1998 Apr;41(4):657-62. doi: 10.1002/1529-0131(199804)41:4<657::AID-ART12>3.0.CO;2-N. Arthritis Rheum. 1998. PMID: 9550474
Fas ligand and immune evasion.
Nagata S. Nagata S. Nat Med. 1996 Dec;2(12):1306-7. doi: 10.1038/nm1296-1306. Nat Med. 1996. PMID: 8946823 No abstract available.
An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand.
Sato K, Kimura F, Nakamura Y, Murakami H, Yoshida M, Tanaka M, Nagata S, Kanatani Y, Wakimoto N, Nagata N, Motoyoshi K. Sato K, et al. Among authors: nagata s, nagata n. Br J Haematol. 1996 Aug;94(2):379-82. doi: 10.1046/j.1365-2141.1996.d01-1799.x. Br J Haematol. 1996. PMID: 8759901
1,833 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page